|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
1,784
-1.6%
10.67
USD 19,035
|
1,784
-1.6%
|
10.67
|
USD 19,035
|
|
|
2024-12-12 |
2024-12-11 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
21,787
-0.5%
20.23
USD 440,751
|
21,787
-0.5%
|
20.23
|
USD 440,751
|
|
|
2024-12-12 |
2024-12-11 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
21,787
-0.5%
20.23
USD 440,751
|
21,787
-0.5%
|
20.23
|
USD 440,751
|
|
|
2024-12-12 |
2024-12-10 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
22,935
-0.5%
20.77
USD 476,360
|
22,935
-0.5%
|
20.77
|
USD 476,360
|
|
|
2024-12-12 |
2024-12-10 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
22,935
-0.5%
20.77
USD 476,360
|
22,935
-0.5%
|
20.77
|
USD 476,360
|
|
|
2024-12-03 |
2024-12-03 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
11,703
-7.5%
20.15
USD 235,786
|
11,703
-7.5%
|
20.15
|
USD 235,786
|
|
|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
4,088
-2.5%
20.26
USD 82,834
|
4,088
-2.5%
|
20.26
|
USD 82,834
|
|
|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
5,000
-6.3%
20.00
USD 99,978
|
5,000
-6.3%
|
20.00
|
USD 99,978
|
|
|
2024-12-03 |
2024-11-29 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
100
-0.1%
20.00
USD 2,000
|
100
-0.1%
|
20.00
|
USD 2,000
|
|
|
2024-12-03 |
2024-11-29 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
1,000
-1.3%
19.97
USD 19,970
|
1,000
-1.3%
|
19.97
|
USD 19,970
|
|
|
2024-11-13 |
2024-11-13 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
2,700
-1.7%
20.04
USD 54,109
|
2,700
-1.7%
|
20.04
|
USD 54,109
|
|
|
2024-11-13 |
2024-11-11 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
1,409
-0.9%
20.01
USD 28,191
|
1,409
-0.9%
|
20.01
|
USD 28,191
|
|
|
2024-11-13 |
2024-11-11 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
8,637
-10.5%
19.98
USD 172,562
|
8,637
-10.5%
|
19.98
|
USD 172,562
|
|
|
2024-11-06 |
2024-11-06 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
2,745
-1.6%
19.32
USD 53,024
|
2,745
-1.6%
|
19.32
|
USD 53,024
|
|
|
2024-11-06 |
2024-11-06 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
9,554
-5.4%
18.71
USD 178,752
|
9,554
-5.4%
|
18.71
|
USD 178,752
|
|
|
2024-11-06 |
2024-11-05 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
5,171
-2.8%
18.18
USD 94,006
|
5,171
-2.8%
|
18.18
|
USD 94,006
|
|
|
2024-11-06 |
2024-11-04 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
749
-0.4%
18.02
USD 13,498
|
749
-0.4%
|
18.02
|
USD 13,498
|
|
|
2024-10-18 |
2024-10-16 |
PS
Planned sale
|
Sethuraman Natarajan
President, Research & Develop.
Officer
|
600
-0.3%
18.00
USD 10,800
|
600
-0.3%
|
18.00
|
USD 10,800
|
|
|
2024-09-30 |
2024-09-26 |
PS
Planned sale
|
Dowden Nathan J
President & COO
Officer
|
847
-0.7%
16.00
USD 13,552
|
847
-0.7%
|
16.00
|
USD 13,552
|
|
|
2024-09-10 |
2024-09-09 |
PS
Planned sale
|
WENTWORTH KORY JAMES
Chief Financial Officer
Officer
|
3,195
-4.0%
14.97
USD 47,832
|
3,195
-4.0%
|
14.97
|
USD 47,832
|
|
